Advertisement

Serum Institute seeks indemnity from liability; says ''rules should be same for everyone'': Sources

Follow The Hawk on Google News+ Follow

Advertisement


New Delhi: Domestic vaccine major Serum Institute of India is seeking indemnity from liability for its COVID vaccines, saying that the rules should be same for all the companies, according to sources.

The development comes after requests for indemnity and exemption from bridging trials have been made by Pfizer and Moderna to the Indian government.

Advertisement

"Rules should be the same for everyone," a source at the Serum Institute said.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

Earlier, Serum Institute CEO Adar Poonawalla had said that vaccine manufacturers need to have protection against all lawsuits for their vaccines, especially during a pandemic.

In December 2020, speaking at an event, he said, "we need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that".

Advertisement

Serum Institute is producing Oxford-AstraZeneca''s COVID vaccine ''Covishield'' in India and clinical trials of its second vaccine ''Covovax'' have begun in the country and the company hopes to launch it by September this year.

—PTI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST